Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
---|---|---|---|---|---|
BIONTECH | 2 | 23 | +0,53 % | ||
REGENERON PHARMACEUTICALS | 1 | 23 | -1,12 % | ||
CUREVAC | 1 | 12 | -0,48 % | ||
ARDELYX | 1 | 7 | +0,17 % | ||
ULTRAGENYX | 1 | 6 | +0,50 % | ||
MAXCYTE | 1 | 3 | 0,00 % | ||
AMGEN | - | 81 | -0,38 % | ||
MODERNA | - | 45 | -0,12 % | ||
DECIPHERA PHARMACEUTICALS | - | 29 | 0,00 % | ||
NEUROCRINE BIOSCIENCES | - | 15 | -0,54 % |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Sa | Ardelyx, Inc. (ARDX) Q1 2024 Earnings Call Transcript | 2 | Insider Monkey | ||
Sa | Ultragenyx Pharmaceutical Inc. (RARE) Q1 2024 Earnings Call Transcript | 1 | Insider Monkey | ||
Sa | CureVac Aktie: Spekulationen treiben Kurs hoch | 1.413 | Börse Global | CureVac, das deutsche Biotechnologieunternehmen, verzeichnete in der letzten Woche eine auffällige Kurssteigerung von 12,65 Prozent auf aktuell 2,9 € pro Aktie. Diese Entwicklung erstaunt auf den ersten... ► Artikel lesen | |
Sa | Astrazeneca gesteht: Schwere Nebenwirkung von Corona-Impfstoff Vaxzevria | 5 | RND.de | ||
Sa | Krank nach Corona-Impfung? Astrazeneca gesteht schwere Nebenwirkung ein | 5 | RND.de | ||
Sa | BioNTech Aktie: Unerwarteter Aufwärtstrend | 885 | Börse Global | Trotz des Fehlens offenkundiger Gründe für einen Anstieg verzeichnet die Aktie des Biotechnologieunternehmens BioNTech ein leichtes Plus von 0,23% auf 86,2 € im Vergleich zur Vorwoche. Dies geschieht... ► Artikel lesen | |
Sa | Unglaubliche Prognose für Montag setzt BioNtech Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! | Felix Haupt | |||
Sa | MaxCyte Inc expected to post a loss of 13 cents a share - Earnings Preview | 1 | Reuters | ||
Sa | Pro Research: Wall Street dives into Regeneron's robust prospects | 5 | Investing.com | ||
Sa | Twist Bioscience Corp reports results for the quarter ended in March - Earnings Summary | 2 | Reuters | ||
Sa | Why Amgen Stock Zoomed Nearly 12% Higher Today | 22 | The Motley Fool | ||
Fr | S&P 500 Gains and Losses Today: Amgen Soars as Weight-Loss Drug Shows Promise | 5 | Investopedia | ||
Fr | ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 42 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO and SAN DIEGO, May 03, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms... ► Artikel lesen | |
Fr | Zymeworks Inc reports results for the quarter ended in March - Earnings Summary | 2 | Reuters | ||
Fr | Vanda Pharmaceuticals Inc. - 8-A12B/A, Registration of securities | 2 | SEC Filings | ||
Fr | Vir Biotechnology, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
Fr | ILLUMINA, INC. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
Fr | Taysha Gene Therapies, Inc.: Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 45 | GlobeNewswire (Europe) | DALLAS, May 03, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the... ► Artikel lesen | |
Fr | Arcutis Biotherapeutics, Inc.: Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 129 | GlobeNewswire (Europe) | WESTLAKE VILLAGE, Calif., May 03, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in... ► Artikel lesen | |
Fr | Terns Pharmaceuticals, Inc.: Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) | 34 | GlobeNewswire (Europe) | FOSTER CITY, Calif., May 03, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule... ► Artikel lesen |